je.st
news
RXi Pharmaceuticals Corp (RXII) Downgraded by Zacks Investment Research to "Sell"
2015-12-19 21:28:21| Biotech - Topix.net
According to Zacks, "RXi Pharmaceuticals Corporation is a biotechnology company focused on discovering, developing and commercializing therapies based on its RNAi platform. The Company is developing RXI-109, which is used for the reduction of dermal scarring in planned surgeries, as well as reduces the expression of connective tissue growth factor.
Tags: research
sell
investment
corp
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||